Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine administered according to two different primary vaccination schedules
Autor: | Angela Moiraghi, Carla Maria Zotti, Anna Giammanco, Renato Soncini, Sarina Pignato, Giuseppe Giammanco, Salvatore Li Volti |
---|---|
Rok vydání: | 1998 |
Předmět: |
Reactogenicity
Hepatitis B vaccine General Veterinary General Immunology and Microbiology Tetanus business.industry Diphtheria Public Health Environmental and Occupational Health Toxoid medicine.disease Vaccination Infectious Diseases Immunology medicine Molecular Medicine Pertactin business Whooping cough |
Zdroj: | Vaccine. 16:722-726 |
ISSN: | 0264-410X |
DOI: | 10.1016/s0264-410x(97)00250-8 |
Popis: | The reactogenicity and immunogenicity of a tetravalent diphtheria-tetanus-acellular pertussis-hepatitis B (DTPa-HB) vaccine (SmithKline Beecham) were studied in 565 infants immunized according to one of two different schedules, at 2, 4 and 6 months of age (group A n = 208) or at 3, 5 and 11 months of age (group B n = 357). The incidences of local and general reactions within the first 8 days after vaccination were similar in the two groups of infants, the vast majority being mild in intensity and occurring within 2-3 days of vaccine administration. Severe local symptoms were rare: pain after 0.6% of all doses, redness after 0.5% and 1.3%, and swelling after 0.3% and 1.5%, in group A and B, respectively. Only one infant in group A and one in group B had a temperature > 39.0 degrees C. Both schedules proved satisfactory in obtaining high levels of antibodies against all antigens. The rates of serologic response against the different antigens reached 100% in both groups. Antibody titres against all vaccine components were elevated following both schedules, but after the third dose of vaccine geometric mean antibody titres (GMTs) against D toxoid, filamentous haemagglutinin (FHA), pertactin (PRN) and hepatitis B (HB) were significantly higher in the 3, 5, 11 group than after the 2, 4, 6 schedule. Antibody titres measured at 7 months of age in the group immunized at 2, 4 and 6 months were higher than those reached at 6 months of age in infants immunized at 3, 5 and 11 months, but FHA and PRN were within the range of DTPa vaccine with proven efficacy. We conclude that DTPa-HB vaccine was safe, well tolerated and highly immunogenic. Both vaccination schedules (2, 4, 6 and 3, 5, 11) can be considered suitable for mass immunization programmes. |
Databáze: | OpenAIRE |
Externí odkaz: |
načítá se...